We develop a cost structure similar to Armbruster and Brandeau that incorporates the various costs to screen for and treat a disease. (3) Given these costs, a single DU chooses the screening level that minimizes its net present value of discounted future costs. We solve for the symmetric, pure-strategy Nash equilibrium.